Fedor Zurabov, from MicroMir, presents a new review proposing Phagobiotics as a framework for defined, quality-controlled bacteriophages designed for selective, non-therapeutic modulation of the gut m...

Paolo Savoca discusses how NexaBiome is integrating AI and machine learning in phage selection to improve host matching and advance personalized phage therapy.

First public hospital in the European Union, Hospices Civils de Lyon authorized to manufacture GMP therapeutic phages, marks a major milestone in the advancement of regulated phage therapy across Euro...

JAFRAL Phage Summit 2026 in Ljubljana, Slovenia. The summit will be held from the 19th to the 21st of May 2026.

Hanson Wade 8th Bacteriophage Therapy Summit 2026 in London, UK. The summit will be held from the 24th to the 26th of March 2026.

NexaBiome has received continued funding from Scotland's national economic development agency, to accelerate its breakthrough bacteriophage technology for the treatment of Diabetic Foot Infections (DF...

Viruses of Microbes 2026 in Prague, Czech Republic. The conference will be held from the 6th to the 10th of July 2026.

MicroMir shares the first comparative clinical evaluation of inhaled phages for multidrug-resistant Klebsiella pneumoniae as an adjunct to antibiotics for ventilator-associated Pneumonia.

Dr. Gladkov and his team share insights into the skin microbiota, skin-gut axis, and the role of phages in acne treatment with bacteriophages.

TechnoPhage PHAXIAM Therapeutics partnership will expand GMP phage availability for individualized phage therapy, providing physicians with comprehensive GMP phages and enhancing treatment options for...

MicroMir shares insights on using Phage Mimir124 against multidrug-resistant Uropathogenic Escherichia coli in a patient with neurogenic bladder dysfunction.

​Welcome to the ultimate resource for all things bacteriophage! Our website is dedicated to collecting and curating the latest news, research, and information about these fascinating viruses that infe...